|
Market Closed -
Nasdaq
16:00:00 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 91.60 USD | -1.60% |
|
-1.29% | -3.78% |
| 08-11 | Tango Therapeutics Q2 Net Loss Widens | MT |
| 08-06 | European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading | MT |
| Market Cap | 19.86B 23.01B 18.64B 16.97B 31.92B 2,200B 32.36B 218B 85.61B 1,102B 86.39B 84.52B 3,667B | P/E 2026 * |
-14.4x | P/E 2027 * | -14.9x |
|---|---|---|---|---|---|
| Enterprise Value | 9.09B 10.52B 8.52B 7.76B 14.6B 1,006B 14.8B 99.92B 39.16B 504B 39.51B 38.66B 1,677B | EV / Sales 2026 * |
4.96x | EV / Sales 2027 * | 5.59x |
| Free-Float |
96.06% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioNTech SE
| 1 day | -1.60% | ||
| 1 week | -1.29% | ||
| Current month | +1.13% | ||
| 1 month | +0.13% | ||
| 3 months | +2.29% | ||
| 6 months | -14.38% | ||
| Current year | -3.78% |
| 1 week | 90.52 |  | 93.8 |
| 1 month | 88.2 | | 94.41 |
| Current year | 79.52 | | 124 |
| 1 year | 79.52 | | 124 |
| 3 years | 76.53 | | 131.49 |
| 5 years | 76.53 | | 388 |
| 10 years | 12.52 | | 464 |
| Manager | Title | Age | Since |
|---|---|---|---|
Özlem Türeci
CTO | Chief Tech/Sci/R&D Officer | 59 | 2017-12-31 |
Ugur Sahin
CEO | Chief Executive Officer | 60 | 2008-06-01 |
| Director of Finance/CFO | - | 2025-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Helmut Jeggle
CHM | Chairman | 55 | 2008-06-01 |
| Director/Board Member | 69 | 2008-06-01 | |
| Director/Board Member | 65 | 2017-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/18/26 | Other | Director | 1,927 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.60% | -1.29% | -19.31% | -19.10% | 23.01B | |
| +4.80% | +3.44% | +70.64% | +109.32% | 73.25B | |
| -1.33% | +12.66% | +47.16% | +88.05% | 61.95B | |
| +3.70% | -4.77% | +0.41% | +484.07% | 28.02B | |
| +5.42% | +5.83% | +56.97% | +21.50% | 24.15B | |
| -6.00% | +6.02% | +244.39% | +430.80% | 18.35B | |
| +1.05% | +6.42% | +40.70% | -13.60% | 19.46B | |
| +3.73% | +2.55% | +21.31% | +556.97% | 15.92B | |
| +2.11% | -1.21% | +36.57% | +149.14% | 12.96B | |
| +2.48% | +0.42% | +332.47% | +205.65% | 12.53B | |
| Average | +1.44% | +1.00% | +83.13% | +201.28% | 28.96B | |
| Weighted average by Cap. | +1.71% | +3.02% | +66.62% | +166.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.83B 2.12B 1.72B 1.56B 2.94B 203B 2.98B 20.13B 7.89B 102B 7.96B 7.79B 338B | 1.86B 2.16B 1.75B 1.59B 3B 206B 3.04B 20.5B 8.03B 103B 8.11B 7.93B 344B |
| Net income | -1.34B -1.55B -1.26B -1.15B -2.15B -148B -2.18B -14.74B -5.78B -74.39B -5.83B -5.7B -247B | -1.34B -1.55B -1.26B -1.14B -2.15B -148B -2.18B -14.73B -5.77B -74.31B -5.82B -5.7B -247B |
| Net Debt | -10.78B -12.49B -10.11B -9.21B -17.32B -1,194B -17.56B -119B -46.45B -598B -46.88B -45.86B -1,990B | -9.44B -10.94B -8.86B -8.07B -15.17B -1,046B -15.38B -104B -40.69B -524B -41.06B -40.17B -1,743B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-17 | US$91.60 | -1.60% | 443,531 |
| 26-08-14 | US$93.09 | +1.05% | 650,531 |
| 26-08-13 | US$92.12 | -0.67% | 988,541 |
| 26-08-12 | US$92.74 | -0.06% | 476,504 |
| 26-08-11 | US$92.80 | 0.00% | 705,979 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BNTX Stock
Select your edition
All financial news and data tailored to specific country editions
